Live Breaking News & Updates on அன்டோனியோ பார்ரா டோரஸ்

Stay updated with breaking news from அன்டோனியோ பார்ரா டோரஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Anvisa allows for limited imports of Sputnik V and Covaxin into Brazil


“Brazil will become the most populated country of South America to use the Russian vaccine,” Dmitriev said.
Brazil s National Health Surveillance Agency (Anvisa) Friday approves, albeit with some restrictions, imports of Covaxin and Sputnik V doses for use in up to 1% of the country s population, it was announced.
The country currently uses CoronaVac, AstraZeneca/Oxford, Pfizer/BioNTech and Janssen immunizers. The new decision applies only to specific batches.
In the case of Covaxin, the authorization defined the amount of 4 million doses, which can only be used under specific conditions determined by the Agency.
As for Sputnik, the number of doses will be restricted to 1% of the population of each of the six requesting states: Bahia, Maranhão, Sergipe, Ceará, Pernambuco and Piauí. ....

United States , Estado De Pernambuco , Astrazeneca Oxford , Kirill Dmitriev , Anvisa Alex Machado Campos , Antonio Barra Torres , Alex Machado , Gustavo Mendes , World Health Organization , Ministry Of Health , Russia Gamaleya Institute , Brazil National Health Surveillance Agency Anvisa , Russian Direct Investment Fund , South America , National Health Surveillance Agency , Gamaleya Institute , Bharat Biotech , National Institute , Quality Control , Anvisa Alex Machado , General Manager , Medicines Gustavo , Anvisa Director President Antonio Barra , ஒன்றுபட்டது மாநிலங்களில் , எஸ்டாடோ டி பரர்ந்யாஂப்யூகொ , அன்டோனியோ பார்ரா டோரஸ் ,

Brazil health regulator chief says analysis of Sputnik vaccine stalled


Brazil health regulator chief says analysis of Sputnik vaccine stalled
Reuters
2 days ago
BRASÍLIA, May 11 (Reuters) - Brazilian health regulator Anvisa s head Antonio Barra Torres said that the analysis of Russia s Sputnik V COVID-19 vaccine is stalled pending arrival of documents requested from its local manufacturing partner Uniao Química.
Torres is testifying on Tuesday before a Senate committee investigating the Brazilian federal government s handling of the COVID-19 pandemic, which has already killed more than 423,000 people and infected more than 15.2 million here. (Reporting by Maria Carolina Marcello Writing by Ana Mano; Editing by Christian Plumb) ....

Antonio Barra Torres , Maria Carolina Marcello Writing , Ana Mano , Christian Plumb , அன்டோனியோ பார்ரா டோரஸ் , மரியா கரோலினா மார்செல்லோ எழுதுதல் , அனா மனோ , கிறிஸ்துவர் ப்லம்‌ப் ,

UPDATE 1-Brazil chief health regulator disagrees with president on vaccines, masks


UPDATE 1-Brazil chief health regulator disagrees with president on vaccines, masks
Reuters
3 days ago
(Recasts to focus on remarks about President Bolsonaro)
BRASÍLIA, May 11 (Reuters) - Brazil s chief health regulator on Tuesday said President Jair Bolsonaro s past skepticism about COVID-19 vaccines contradicts his agency s position and public statements, stressing the need immunize the population to contain the pandemic.
Testifying before a Senate committee investigating the Brazilian federal government s handling of the COVID-19 health crisis, Antonio Barra Torres, head of health regulator Anvisa, also disagreed with Bolsonaro on masks and social distancing.
We understand, contrary to what you just read, that the vaccination policy is essential, he told a senator asking about Bolsonaro s past public remarks downplaying the usefulness of vaccines. ....

Antonio Barra Torres , Jair Bolsonaro , President Bolsonaro , President Jair Bolsonaro , Maria Carolina Marcello Writing , Ana Mano , Christian Plumb , அன்டோனியோ பார்ரா டோரஸ் , ஜெயர் போல்சனாரோ , ப்ரெஸிடெஂட் போல்சனாரோ , ப்ரெஸிடெஂட் ஜெயர் போல்சனாரோ , மரியா கரோலினா மார்செல்லோ எழுதுதல் , அனா மனோ , கிறிஸ்துவர் ப்லம்‌ப் ,